Farmingdale Wins $2.3 Million Grant from NYS
January 4, 2016
Farmingdale has been awarded a $2.3M grant by NYS, in collaboration with Codagenix, Inc., Nassau Community College, and Broad Hollow Bioscience Park. Codagenix, a synthetic-biology company commercializing a platform for vaccine development, is soon to be based on campus at BHBP as part of the state’s START-UP NY program.
Aside from this grant, Codagenix has raised more than $4M in private and public support. The new grant, which is funneled through the LI Regional Economic Development Council, funds capital expenditures in support of research into the development of numerous vaccines for diseases such as Influenza, RSV, and E. Coli. These funds seek to lay the groundwork for establishing a biotech innovation pipeline that runs from middle school through college.
FSC biology Professor J. Robert Coleman, a Codagenix co-founder, said about the grant: “This is an exciting first step in establishing a public/private consortium of innovation in the field of vaccine development. Codagenix is the prototype SUNY spin-out, start-up company. Codagenix is commercializing a SUNY technology and in doing so we are employing SUNY graduates. The vaccine discovery consortium supported by this grant will further enable future discovery and economic growth for Long Island’s growing biotech sector.”
President Keen said “Codagenix is at the forefront of research on creating immunity in biological systems, and this funding will assist this important resident of Farmingdale State’s Broad Hollow Bioscience Park to advance its research and reach practical applications of its intellectual products.”